You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>
Fresenius Medical Care AG & Co. KGaA (FMS) - free report >>
WidePoint Corporation (WYY) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 9th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Chain Bridge Bancorp, Inc. (CBNA - Free Report) : This bank holding company for Chain Bridge Bank, N.A. has seen the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.
Chain Bridge Bancorp, Inc. Price and Consensus
Chain Bridge Bancorp, Inc. price-consensus-chart | Chain Bridge Bancorp, Inc. Quote
Fresenius Medical Care AG (FMS - Free Report) : This dialysis and related services company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
Fresenius Medical Care AG & Co. KGaA Price and Consensus
Fresenius Medical Care AG & Co. KGaA price-consensus-chart | Fresenius Medical Care AG & Co. KGaA Quote
Brenntag SE (BNTGY - Free Report) : This distributor of chemicals and ingredients has seen the Zacks Consensus Estimate for its next year earnings increasing 14.1% over the last 60 days.
Brenntag AG Price and Consensus
Brenntag AG price-consensus-chart | Brenntag AG Quote
WidePoint Corporation (WYY - Free Report) : This company that provides technology management as a service (TMaaS) has seen the Zacks Consensus Estimate for its current year earnings increasing 108.3% over the last 60 days.
WidePoint Corporation Price and Consensus
WidePoint Corporation price-consensus-chart | WidePoint Corporation Quote
BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 285.7% over the last 60 days.
BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.